Moving from chemotherapy to targeted or immune treatment

Switching from chemotherapy to targeted therapy or immunotherapy is possible when the cancer has a feature these medicines can act on, or when the cancer type is known to respond to them. Targeted medicines are designed to block particular changes in cancer cells, such as an altered gene or an overactive protein. Immune treatments help the body's own defences recognise and attack cancer. Neither works for everyone, and neither is automatically better than chemotherapy. For some cancers these options are already part of standard care; for others they are used only in selected situations or within clinical trials. Your oncologist looks carefully at the whole picture, including your health and earlier treatment, before suggesting a switch.

Testing is usually the key first step. Many targeted medicines only make sense if a specific change is found in the cancer, and some immune treatments are guided by markers on the cancer cells. Tests may be run on tissue that was removed earlier, but when chemotherapy has stopped working the cancer may have changed, so a fresh tissue sample is sometimes advised. A blood test that detects fragments of cancer material can help in some cases, especially when a tissue sample is difficult to obtain. Results can take a while, and not every test finds something treatable, so it helps to ask early what each result could realistically lead to for you.

Is it available here? CION oncologists can discuss whether targeted therapy or immunotherapy suits your cancer, arrange the appropriate tests, some of which are processed by specialist laboratories, and explain clearly how treatment would be given and monitored. Ask which centre would deliver your treatment. Availability of a particular medicine can depend on approvals for your cancer type, supply and cost. Some newer medicines are expensive, and insurance or assistance programmes vary, so an honest conversation about money belongs early in the process. A switch is also not the only path: further chemotherapy, a clinical trial, a pause or comfort-focused care remain valid choices, and the decision rests with you and your family, guided by your oncologist.

A switch needs a reason

Tests or the cancer type must point towards it.

Testing may need a fresh sample

Cancers can change after chemotherapy stops working.

Not the only option

Other treatment, trials, a pause or comfort-focused care remain.

It cannot tell you whether your cancer has a change that targeted or immune treatment can act on. Only testing can show that.

It also cannot say whether a switch would help you personally. Your oncologist interprets results in context.

Targeted therapy in plain words

Targeted medicines are designed to block a specific change that helps some cancer cells grow. If the cancer has that change, the medicine may slow it. If it does not, the medicine is unlikely to help, which is why testing matters so much before a switch is suggested.

Immunotherapy in plain words

Immune treatments release some of the brakes that cancer places on the immune system, so the body's defences can attack it. They can cause unusual side effects, because the immune system may also affect healthy organs. These effects are often manageable when reported early and treated promptly.

Why a fresh sample may be needed

Cancer cells can change after chemotherapy stops working. A sample taken at diagnosis may not reflect the cancer today, or may have too little tissue left to test. A fresh sample can give an up-to-date picture, although it involves a procedure and some waiting. Your team explains the likely wait.

Blood tests for cancer material

Some cancers shed small fragments of genetic material into the bloodstream. A blood test can sometimes detect changes in these fragments, avoiding a procedure. However, a negative result does not always mean the change is absent, so for some patients a tissue sample may still be recommended afterwards.

When nothing treatable is found

Many cancers do not carry a change that current targeted medicines can act on. That is disappointing, but it does not mean care stops. Further chemotherapy, radiotherapy for a troublesome area, a clinical trial or comfort-focused care may still be discussed openly with you and your family.

Combining treatments

For some cancers, targeted or immune medicines are given together with chemotherapy rather than replacing it. The combination may suit some people and not others, depending on fitness and side effects. Ask whether the plan is a switch, an addition, or a sequence of treatments used one after another.

Side effects feel different

Targeted medicines can cause skin rashes, loose motions, changes in blood pressure or liver tests. Immune treatments can inflame the bowel, lungs, liver, skin or hormone glands. These effects differ from chemotherapy, so learn which ones need urgent attention and keep your team's contact number always close.

Tablets taken at home

Many targeted treatments are tablets or capsules taken at home. They can feel less intrusive, but they are powerful medicines. Regular blood tests and reviews remain important. Do not stop, skip or change them without talking to your oncologist first, and mention any other medicines you use.

Cost and access

Some targeted and immune medicines carry a high cost, and cover varies between insurance plans and government schemes. Manufacturer assistance programmes exist for certain medicines. Ask for a written estimate and help with the paperwork before starting, so that money questions do not interrupt treatment unexpectedly later on.

Clinical trials of newer medicines

Research into targeted and immune medicines moves quickly, and some are available only through trials. A trial may require specific test results, extra visits and scans. Taking part is voluntary and you can withdraw at any time. Your oncologist can check whether any open trial matches your cancer.

When a switch is not right

Even when tests find a change, a switch may not suit every person. General health, other illnesses, side effect concerns or personal wishes can all weigh against it. Choosing not to switch, or choosing comfort-focused care, is a legitimate decision made with your oncologist and your family.

Supportive care throughout

Whatever treatment follows, a supportive care team can help with symptoms, sleep, appetite and worry. This care works alongside targeted or immune treatment, not instead of it, and can be arranged at any time. Asking for it early often makes the whole journey feel more manageable.

What to do next

Ask whether your cancer has been tested, whether a fresh sample or blood test is advised, what results could change, how targeted or immune treatment would be given, what it would cost, and which other options, including trials and comfort-focused care, remain.